@hideta77.bsky.social
Reposted
👩⚕️👨🔬 Why do people attend #EACS2025? Hear it straight from previous participants! Watch their testimonials and see why Paris is the place to be this October. 🌟 Register now and join the global conversation on HIV: https://loom.ly/cOdLETc
#HIV #EACS2025 #Paris #MedicalCommunity
#HIV #EACS2025 #Paris #MedicalCommunity
September 30, 2025 at 2:05 PM
👩⚕️👨🔬 Why do people attend #EACS2025? Hear it straight from previous participants! Watch their testimonials and see why Paris is the place to be this October. 🌟 Register now and join the global conversation on HIV: https://loom.ly/cOdLETc
#HIV #EACS2025 #Paris #MedicalCommunity
#HIV #EACS2025 #Paris #MedicalCommunity
Pleased to inform that a consortium of Japanese doctors has published a paper on LAI. I’m honored to be listed as a co-author. Prof. Orkin encouraged us to form the consortium. We appreciate your support. @profchloeorkin.bsky.social @toshtaniguc.bsky.social
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics
Objectives Long-acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real-world data in East Asia remain scarce. This study aims to evaluate the impact of ...
onlinelibrary.wiley.com
August 13, 2025 at 2:45 AM
Pleased to inform that a consortium of Japanese doctors has published a paper on LAI. I’m honored to be listed as a co-author. Prof. Orkin encouraged us to form the consortium. We appreciate your support. @profchloeorkin.bsky.social @toshtaniguc.bsky.social
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...